These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 12838269)

  • 21. Cancer biomarkers: current issues and future directions.
    Jain KK
    Curr Opin Mol Ther; 2007 Dec; 9(6):563-71. PubMed ID: 18041667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implications of salivary proteomics in drug discovery and development: a focus on cancer drug discovery.
    Hu S; Yen Y; Ann D; Wong DT
    Drug Discov Today; 2007 Nov; 12(21-22):911-6. PubMed ID: 17993408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biomarkers: a valuable tool in clinical research and medical practice.
    Carini C
    IDrugs; 2007 Jun; 10(6):395-8. PubMed ID: 17642003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How molecular profiling could revolutionize drug discovery.
    Stoughton RB; Friend SH
    Nat Rev Drug Discov; 2005 Apr; 4(4):345-50. PubMed ID: 15789121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery and development of biomarkers of neurological disease.
    Dunckley T; Coon KD; Stephan DA
    Drug Discov Today; 2005 Mar; 10(5):326-34. PubMed ID: 15749281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteomics in atherothrombosis: a future perspective.
    Martín-Ventura JL; Blanco-Colio LM; Tunon J; Gomez-Guerrero C; Michel JB; Meilhac O; Egido J
    Expert Rev Proteomics; 2007 Apr; 4(2):249-60. PubMed ID: 17425460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteomics in clinical interventions: achievements and limitations in biomarker development.
    Sinha A; Singh C; Parmar D; Singh MP
    Life Sci; 2007 Mar; 80(15):1345-54. PubMed ID: 17210164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Translational studies for target-based drugs.
    Nishio K; Arao T; Shimoyama T; Fujiwara Y; Tamura T; Saijo N
    Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():90-3. PubMed ID: 16273363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alzheimer's disease cerebrospinal fluid biomarker discovery: a proteomics approach.
    D'Ascenzo M; Relkin NR; Lee KH
    Curr Opin Mol Ther; 2005 Dec; 7(6):557-64. PubMed ID: 16372405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Challenges of cancer biomarker profiling.
    Bensalah K; Montorsi F; Shariat SF
    Eur Urol; 2007 Dec; 52(6):1601-9. PubMed ID: 17919807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strategies for discovering novel cancer biomarkers through utilization of emerging technologies.
    Kulasingam V; Diamandis EP
    Nat Clin Pract Oncol; 2008 Oct; 5(10):588-99. PubMed ID: 18695711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biomarkers in acute cardiac disease: the present and the future.
    Jaffe AS; Babuin L; Apple FS
    J Am Coll Cardiol; 2006 Jul; 48(1):1-11. PubMed ID: 16814641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Translating genomic biomarkers into clinically useful diagnostics.
    Ginsburg GS; Haga SB
    Expert Rev Mol Diagn; 2006 Mar; 6(2):179-91. PubMed ID: 16512778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer proteomics and its application to discovery of therapy response markers in human cancer.
    Smith L; Lind MJ; Welham KJ; Cawkwell L;
    Cancer; 2006 Jul; 107(2):232-41. PubMed ID: 16752413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Casting light on molecular events underlying anti-cancer drug treatment: what can be seen from the proteomics point of view?
    Kraljevic S; Sedic M; Scott M; Gehrig P; Schlapbach R; Pavelic K
    Cancer Treat Rev; 2006 Dec; 32(8):619-29. PubMed ID: 17069979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncoproteomics: current trends and future perspectives.
    Cho WC; Cheng CH
    Expert Rev Proteomics; 2007 Jun; 4(3):401-10. PubMed ID: 17552924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical proteomics and biomarker discovery.
    Johann DJ; McGuigan MD; Patel AR; Tomov S; Ross S; Conrads TP; Veenstra TD; Fishman DA; Whiteley GR; Petricoin EF; Liotta LA
    Ann N Y Acad Sci; 2004 Jun; 1022():295-305. PubMed ID: 15251975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The increasing importance of genetic variation in drug discovery and development.
    Labaudinière R
    Curr Opin Mol Ther; 2002 Dec; 4(6):559-64. PubMed ID: 12596357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identifying novel biomarkers for cardiovascular disease risk prediction.
    Ge Y; Wang TJ
    J Intern Med; 2012 Nov; 272(5):430-9. PubMed ID: 22950687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and use of biomarkers in oncology drug development.
    Floyd E; McShane TM
    Toxicol Pathol; 2004; 32 Suppl 1():106-15. PubMed ID: 15209410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.